Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SwedenBack to Sweden

Clinical trials in Linkoping – page 7

180 clinical trials in Linkoping, Sweden across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Linkoping at a glance
180
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

180 trials in Linkoping

Open in trial search

Acute myeloid leukaemia

Recruiting

Study on the Safety and Effectiveness of Quizartinib for Children with Newly Diagnosed FLT3-ITD Positive AML and Normal NPM1

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Quizartinib Dihydrochloride
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Atrial fibrillation+2

Recruiting

Study on Dapagliflozin for Reducing Atrial Fibrillation and Kidney Injury in Patients Awaiting Coronary Artery Bypass Surgery

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Region Oerebro Laen

Stress cardiomyopathy

Recruiting

Study on the Effects of Adenosine, Dipyridamole, and Apixaban in Patients with Takotsubo Syndrome

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Adenosine
  • Sponsor:Vaestra Goetalandsregionen

Atrial fibrillation+2

Recruiting

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital

Acute lymphocytic leukaemia

Recruiting

Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Asparaginase
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Anaplastic large cell lymphoma T- and null-cell types

Recruiting

Study on Vinblastine for Children and Adolescents with Standard Risk ALK-Positive Anaplastic Large Cell Lymphoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Vinblastine Sulfate
  • Sponsor:GPOH gGmbH

Ewing's sarcoma

Recruiting

Study on Ewing Sarcoma Treatment with Vinorelbine and Drug Combination for Patients with Primary and Disseminated Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Cyclophosphamide
  • Sponsor:GPOH gGmbH

Brain neoplasm

Recruiting

Study on Lithium Sulphate to Prevent Cognitive Impairment in Children After Brain Tumor Radiotherapy

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Lithium Sulphate, Anhydrous
  • Sponsor:Karolinska University Hospital

Alpha-1 antitrypsin deficiency

Recruiting

Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease and Fibrosis

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Fazirsiran
  • Sponsor:Takeda Development Center Americas Inc.

Pre-eclampsia

Recruiting

Study on Metformin for Prolonging Pregnancy in Women with Preterm Preeclampsia

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Metformin Hydrochloride
  • Sponsor:University Of Gothenburg

Glomerulonephritis rapidly progressive

Recruiting

Study on the Safety and Tolerability of Lixudebart and Rituximab for Patients with Rapidly Progressive Glomerulonephritis Due to ANCA-Associated Vasculitis

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Lixudebart
  • Sponsor:Alentis Therapeutics AG

Atypical teratoid/rhabdoid tumour of CNS

Recruiting

Study on Atypical Teratoid/Rhabdoid Tumors in Children Using Dactinomycin, Carboplatin, and Cyclophosphamide

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Carboplatin
  • Sponsor:GPOH gGmbH

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Linkoping

What the registry says about research in the country

01 Cardiovascular & Metabolic Research

Groundbreaking studies focusing on atrial fibrillation prevention and treatment of chronic kidney disease with hypertension. Research includes novel therapies for stroke prevention and innovative drug combinations for metabolic conditions.

  • Stroke Prevention Trials
  • Hypertension Management
  • Metabolic Disorders

Current studies evaluate new anticoagulants and combination therapies for better patient outcomes.

02 Oncology Studies

Comprehensive research into various cancer types, including lymphocytic leukemia, testicular cancer, and esophageal carcinoma. Studies focus on optimizing treatment sequences and exploring new therapeutic approaches.

  • Hematological Malignancies
  • Solid Tumors
  • Pediatric Oncology

Investigations include both conventional and innovative treatment strategies.

03 Neurological & Mental Health

Innovative research examining prolonged grief disorder and major depressive disorder. Studies investigate novel therapeutic approaches and hormone effects on decision-making processes.

  • Depression Treatment
  • Behavioral Studies
  • Hormone Research

Research combines pharmacological interventions with behavioral assessments.

Back to SwedenAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.